Aptose Biosciences Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 02, 2021 / 06:00PM GMT
Megan Dorogi -

Good afternoon, everyone. My name is Megan Dorogi. I'm an Analyst in Jefferies Healthcare Investment Banking. It is my pleasure to introduce Bill Rice, President, Chairman and CEO of Aptose Biosciences, to present at our virtual health care conference.

So without further ado, I will hand it over to Bill.

William G. Rice - Aptose Biosciences Inc. - Chairman, President & CEO

Good afternoon. Thank you, Megan, for giving us the opportunity to present at the Jefferies Healthcare Conference. So first, I'll remind everyone that today, I will make certain forward-looking statements. Also, today's presentation is intended more toward providing an introduction to a new audience because many of the investors who follow us are aware that next week we plan to release all of our new clinical data as part of the European Hematology Association, or EHA Conference.

So for those of you who are new to the story, Aptose is a clinical stage biotech company, and we develop small molecule targeted agents for the treatment of life-threatening hematologic

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot